Peak6 Investments LLC Seagen Inc. Transaction History

Peak6 Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$117.37 - $139.17 $36,619 - $43,421	312 Added 14.25%	2,501 $321,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $295,700 - $393,720	2,186 Added 72866.67%	2,189 $300,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $203,801 - $335,885	-1,873 Reduced 99.84%	3 $1,000
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $172,716 - $227,935	1,444 Added 334.26%	1,876 $270,000
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $61,590 - $82,451	432 New	432 $67,000

Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $430,768 - $513,535	-3,024 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $1.63 Million - $1.95 Million	-12,097 Reduced 80.0%	3,024 $477,000
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $436,731 - $605,980	3,176 Added 26.59%	15,121 $2.1 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $1.97 Million - $2.53 Million	11,945 New	11,945 $2.09 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.